JQUA
Quality FactorJPMorgan U.S. Quality Factor ETF
JPMorgan · Tracks JP Morgan US Quality Factor Index · Inception Nov 8, 2017
Composite score
Based on a 0.12% expense ratio.
Based on $8.16B in net assets.
Top-10 holdings represent 19.0% of net assets.
Quality Factor base · ETF wrapper · 1.08% TTM yield.
The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. See methodology for formulas, the tracking-quality partial-coverage rationale, and the dimensions we deliberately don't score (methodology v0.5.1).
Use JQUA in our tools
Tool · Cost
Compare JQUA's fee against another fund
Compounds the 0.12% expense ratio against a peer over decades.
Tool · Overlap
Compare JQUA's holdings with peers
Pairwise holdings heatmap, pre-loaded with similar Quality Factor funds.
Tool · TLH
Find a tax-loss harvesting partner for JQUA
Ranks every catalog fund by holdings overlap, flags wash-sale risk.
Tool · Placement
Where should this fund live across your accounts?
Asset-location optimizer — places each fund in taxable / tax-deferred / Roth.
Top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Alphabet, Inc. | 2.35% |
| 2 | Broadcom, Inc. | 2.11% |
| 3 | NVIDIA Corp. | 2.05% |
| 4 | Apple, Inc. | 2.01% |
| 5 | Exxon Mobil Corp. | 1.89% |
| 6 | Berkshire Hathaway, Inc. | 1.77% |
| 7 | Meta Platforms, Inc. | 1.71% |
| 8 | Johnson & Johnson | 1.70% |
| 9 | Visa, Inc. | 1.70% |
| 10 | Microsoft Corp. | 1.66% |
Compare JQUA with another fund
Or skim the closest-overlap funds below.
Similar ETFs by holdings overlap
Open JQUA at a brokerage
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.